These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1832419)

  • 21. Clinical efficacy and safety of teicoplanin.
    Stille W; Sietzen W; Dieterich HA; Fell JJ
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():69-79. PubMed ID: 2965134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.
    Glupczynski Y; Lagast H; Van der Auwera P; Thys JP; Crokaert F; Yourassowsky E; Meunier-Carpentier F; Klastersky J; Kains JP; Serruys-Schoutens E
    Antimicrob Agents Chemother; 1986 Jan; 29(1):52-7. PubMed ID: 2942100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teicoplanin: a well-tolerated and easily administered alternative to vancomycin for gram-positive infections in intensive care patients.
    Charbonneau P; Harding I; Garaud JJ; Aubertin J; Brunet F; Domart Y
    Intensive Care Med; 1994 Nov; 20 Suppl 4():S35-42. PubMed ID: 7699155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997].
    Klastersky J
    Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients.
    Nováková IR; Donnelly JP; Verhagen CS; De Pauw BE
    J Antimicrob Chemother; 1990 Jun; 25(6):985-93. PubMed ID: 2142486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ceftazidime for the treatment of infections in neutropenic children].
    Leverger G; Arlet G; Bancillon A; Schaison G
    Presse Med; 1988 Oct; 17(37):1974-6. PubMed ID: 2973600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy and tolerance of teicoplanin in postoperative infections caused by gram-positive microorganisms].
    Alberghina A; Romeo B; Pessione E; Mauri A; Enrichens F; Sciascia C; Olivero G
    Minerva Chir; 1987 Sep; 42(17):1339-45. PubMed ID: 2959879
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of teicoplanin for enterococcal infections: 63 cases and review.
    Schmit JL
    Clin Infect Dis; 1992 Aug; 15(2):302-6. PubMed ID: 1387808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA.
    LeFrock JL; Ristuccia AM; Ristuccia PA; Quenzer RW; Haggerty PG; Allen JE; Lettau LA; Schwartz R; Appleby D
    Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic teicoplanin during insertion of Hickman catheters.
    Lim SH; Smith MP; Machin SJ; Goldstone AH
    Br J Haematol; 1990 Dec; 76 Suppl 2():27-9. PubMed ID: 2149048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children.
    Schaison G; Baruchel A; Arlet G
    Br J Haematol; 1990 Dec; 76 Suppl 2():24-6. PubMed ID: 2149047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teicoplanin in the treatment of skin and soft tissue infections: results of a multicentre study.
    Lang E; Földes M; Marghescu S
    Infection; 1991; 19(3):190-4. PubMed ID: 1832418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of double beta-lactam combinations with netilmicin/ureidopenicillin regimens in the empirical therapy of febrile neutropenic patients.
    Kibbler CC; Prentice HG; Sage RJ; Hoffbrand AV; Brenner MK; Mannan P; Warner P; Bhamra A; Noone P
    J Antimicrob Chemother; 1989 May; 23(5):759-71. PubMed ID: 2668246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of bone, joint, and vascular-access-associated gram-positive bacterial infections with teicoplanin.
    Greenberg RN
    Antimicrob Agents Chemother; 1990 Dec; 34(12):2392-7. PubMed ID: 2150908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teicoplanin compared to flucloxacillin for antibiotic treatment of neutropenic patients.
    Smith CL; Milliken S; Powles R; Da Costa F; Gore M; Benjamin S; Talbot D; Ellis L; Large J; Jameson B
    Br J Haematol; 1990 Dec; 76 Suppl 2():6-9. PubMed ID: 2149055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections.
    Cruciani M; Navarra A; Di Perri G; Andreoni M; Danzi MC; Concia E; Bassetti D
    Clin Infect Dis; 1992 Aug; 15(2):285-9. PubMed ID: 1387805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of serious gram-positive infections with teicoplanin.
    Davies AJ; Stone JM; Synott M
    Drugs Exp Clin Res; 1989; 15(1):29-31. PubMed ID: 2526010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative efficacy and safety study of teicoplanin plus aztreonam versus gentamicin plus piperacillin in haematology oncology patients with clinically diagnosed septicaemia.
    Spencer RC; Taylor AK; Winfield DA
    Br J Haematol; 1990 Dec; 76 Suppl 2():30-4. PubMed ID: 2149049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.